aap Implantate AG publishes interim sales figures for the fourth quarter and full financial year 2004

aap Implantate AG, a medical technology company specialized in healing bone fractures, joint replacement and bone growth and replacement substances, realized in the fourth quarter of 2004 interim sales of EUR 2.954 million, a 28.5% year-on-year increase (Q4 2003: EUR 2.298 million), thereby more than offsetting the reduced first-half revenues. In the full financial year 2004 the Group's interim sales revenues totaled EUR 11.53 million, a 5.2% increase on the previous year's EUR 10.96 million.

aap · mebio expects the positive trend in the fourth quarter of 2004 to continue in the current financial year.

aap Implantate AG's full financial statements for 2004 will be published on March 31, 2005.